Author: Dorron Blumberg

Hialeah Hospital Earns Get With The Guidelines-Stroke Gold Plus Quality Achievement Award

Posted by | Aug 5, 2020 | |

American Heart Association Award recognizes Hialeah Hospital’s commitment to quality stroke care
 
August 6, 2020 – Hialeah Hospital achieves the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
 

Read More

Medicare Moving Forward with Planned E/M Office Visit Changes

Posted by | Aug 4, 2020 | |

 AMA helping physician practices get full benefit of simplified coding and documentation guidelines


August 4 2020 – Major modifications are coming to the coding,  documentation, and payment of evaluation and management (E/M) services for office visits as Medicare has signaled its intention to implement finalized guidelines and payment rates as planned on January 1, 2021. Yesterday’s release of the proposed 2021 Medicare physician payment schedule reconfirmed the designated implementation date announced last November by the Centers for Medicare & Medicaid Services (CMS).



Read More

NIH clinical trial to test antibodies and other experimental therapeutics for mild and moderate COVID-19

Posted by | Aug 4, 2020 | |

Initial trial to determine if monoclonal antibodies can shorten severity of COVID-19 in outpatients.
 
August 4 2020 – A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease. Researchers sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, are working with clinical sites to identify potential patient volunteers currently infected with SARS-CoV-2, the virus which causes COVID-19, who have mild to moderate disease not requiring hospitalization. They will be invited to take an experimental therapy or a placebo as part of a rigorously designed randomized clinical trial. The trial, which is known as ACTIV-2, also may investigate other experimental therapeutics later under the same trial protocol.
 

Read More

Florida Medical Association Installs Michael Patete, MD, FACS, of Venice as 144th FMA President

Posted by | Aug 3, 2020 | |

August 3 2020 –  Michael Patete, MD, FACS, of Venice, Fla., was installed as 144th President of the Florida Medical Association (FMA) on Sunday, Aug. 2, during the all-virtual 2020 FMA Annual Meeting. Dr. Patete, a Board-certified otolaryngologist in private practice who also specializes in head and neck plastic surgery, has been practicing medicine for more than 30 years.

Read More